Compare IDYA & COLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | COLM |
|---|---|---|
| Founded | 2015 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.9B |
| IPO Year | 2019 | 1997 |
| Metric | IDYA | COLM |
|---|---|---|
| Price | $31.70 | $62.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $52.86 | ★ $62.50 |
| AVG Volume (30 Days) | ★ 1.5M | 537.2K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ 3.24 |
| Revenue | $218,710,000.00 | ★ $3,042,478,000.00 |
| Revenue This Year | N/A | $3.73 |
| Revenue Next Year | $201.05 | $3.29 |
| P/E Ratio | ★ N/A | $19.73 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $16.82 | $47.48 |
| 52 Week High | $39.28 | $67.91 |
| Indicator | IDYA | COLM |
|---|---|---|
| Relative Strength Index (RSI) | 46.97 | 67.53 |
| Support Level | $29.51 | $53.13 |
| Resistance Level | $34.76 | $64.45 |
| Average True Range (ATR) | 2.02 | 1.73 |
| MACD | 0.09 | 0.92 |
| Stochastic Oscillator | 19.44 | 80.68 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. It sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.